Cambridge Investment Research Advisors’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $811K | Buy |
1,550
+352
| +29% | +$168K | ﹤0.01% | 2354 |
|
|
2025
Q4 | $698K | Sell |
1,198
-73
| -6% | -$37.3K | ﹤0.01% | 2420 |
|
|
2025
Q3 | $583K | Buy |
1,271
+33
| +3% | +$12.3K | ﹤0.01% | 2523 |
|
|
2025
Q2 | $375K | Buy |
1,238
+90
| +8% | +$26.8K | ﹤0.01% | 2794 |
|
|
2025
Q1 | $380K | Sell |
1,148
-3
| -0.3% | -$986 | ﹤0.01% | 2676 |
|
|
2024
Q4 | $355K | Sell |
1,151
-278
| -19% | -$78.2K | ﹤0.01% | 2707 |
|
|
2024
Q3 | $303K | Sell |
1,429
-900
| -39% | -$230K | ﹤0.01% | 2824 |
|
|
2024
Q2 | $652K | Sell |
2,329
-55
| -2% | -$13.1K | ﹤0.01% | 2079 |
|
|
2024
Q1 | $637K | Sell |
2,384
-3,773
| -61% | -$889K | ﹤0.01% | 2058 |
|
|
2023
Q4 | $1.43M | Sell |
6,157
-857
| -12% | -$150K | 0.01% | 1423 |
|
|
2023
Q3 | $1.02M | Sell |
7,014
-54
| -0.8% | -$10.2K | ﹤0.01% | 1566 |
|
|
2023
Q2 | $1.63M | Buy |
7,068
+448
| +7% | +$121K | 0.01% | 1290 |
|
|
2023
Q1 | $1.6M | Sell |
6,620
-5,940
| -47% | -$1.62M | 0.01% | 1258 |
|
|
2022
Q4 | $3.65M | Buy |
12,560
+4,710
| +60% | +$461K | 0.02% | 750 |
|
|
2022
Q3 | $510K | Buy |
7,850
+100
| +1% | +$6.95K | ﹤0.01% | 1921 |
|
|
2022
Q2 | $555K | Sell |
7,750
-600
| -7% | -$44.1K | ﹤0.01% | 1880 |
|
|
2022
Q1 | $819K | Buy |
8,350
+1,000
| +14% | +$84.3K | ﹤0.01% | 1709 |
|
|
2021
Q4 | $623K | Sell |
7,350
-1,000
| -12% | -$82.2K | ﹤0.01% | 1936 |
|
|
2021
Q3 | $666K | Hold |
8,350
| – | – | ﹤0.01% | 1825 |
|
|
2021
Q2 | $813K | Sell |
8,350
-8,710
| -51% | -$1.03M | ﹤0.01% | 1695 |
|
|
2021
Q1 | $2M | Buy |
17,060
+1,000
| +6% | +$117K | 0.01% | 1010 |
|
|
2020
Q4 | $1.78M | Buy |
16,060
+400
| +3% | +$48.9K | 0.01% | 982 |
|
|
2020
Q3 | $1.86M | Buy |
15,660
+100
| +0.6% | +$10.9K | 0.01% | 840 |
|
|
2020
Q2 | $1.76M | Buy |
15,560
+700
| +5% | +$68.8K | 0.01% | 829 |
|
|
2020
Q1 | $992K | Buy |
14,860
+50
| +0.3% | +$4.17K | 0.01% | 975 |
|
|
2019
Q4 | $1.35M | Buy |
14,810
+210
| +1% | +$20.4K | 0.01% | 990 |
|
|
2019
Q3 | $1.26M | Sell |
14,600
-100
| -0.7% | -$9.38K | 0.01% | 953 |
|
|
2019
Q2 | $1.54M | Buy |
14,700
+300
| +2% | +$32.1K | 0.01% | 817 |
|
|
2019
Q1 | $1.8M | Buy |
14,400
+1,702
| +13% | +$212K | 0.02% | 761 |
|
|
2018
Q4 | $1.43M | Buy |
12,698
+10,700
| +536% | +$1.66M | 0.02% | 772 |
|
|
2018
Q3 | $428K | Sell |
1,998
-1,009
| -34% | -$253K | ﹤0.01% | 1540 |
|
|
2018
Q2 | $841K | Sell |
3,007
-8,075
| -73% | -$1.42M | 0.01% | 1081 |
|
|
2018
Q1 | $1.29M | Buy |
11,082
+2,325
| +27% | +$287K | 0.01% | 810 |
|
|
2017
Q4 | $804K | Buy |
8,757
+900
| +11% | +$51.4K | 0.01% | 1019 |
|
|
2017
Q3 | $353K | Buy |
+7,857
| New | +$147K | ﹤0.01% | 1460 |
|
Other funds holding MDGL
BBA
RI
ACA
PC
VPM
VCM
